Latest Artios Pharma News & Updates

See the latest news and media coverage for Artios. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Artios Pharma (Artios)

Clinical-stage oncology drug development company

artios.com
Headquarters
Cambridge, United Kingdom
Company type
Private company
Number of employees
120–200
Industry
Pharmaceuticals

Last updated

Latest news about Artios Pharma (Artios)

In short: Artios dosed the first patient in its Phase 2 POLKA trial of ART6043 plus olaparib.

Company announcements

Artios

Artios announces Phase 1/2a data for Polθ inhibitor ART6043

ART6043 showed a benign tolerability profile and promising clinical signals with olaparib in advanced solid tumors, supporting advancement into Phase 2 development.

Unlock all announcements with a

Media coverage

London School of Economics and Political Science

Artios raises $153m in Series C financing

LONDON, 27 July 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today...

BioWorld

Artios gets $30M up front in DDR-focused deal with Merck; up to $860M per target

LONDON - DNA damage repair (DDR) specialist Artios Pharma Ltd. has sealed a $860 million per target deal with Merck KGaA, around a series of...

Unlock all articles with a

Never miss news about Artios

Track Artios and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.